Yüklüyor......
Resistance Mechanisms to Taxanes and PARP Inhibitors in Advanced Prostate Cancer
The clinical landscape concerning advanced prostate cancer is rapidly changing and reaching beyond androgen deprivation therapy and androgen receptor targeted therapies. Taxane chemotherapy is a critical tool in the management of advanced prostate cancer. Additionally, novel drug classes such as PAR...
Kaydedildi:
| Yayımlandı: | Curr Opin Endocr Metab Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7111181/ https://ncbi.nlm.nih.gov/pubmed/32258820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coemr.2020.02.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|